The future in paediatric respirology

Respirology

Volumn 15, Issue 5, 2010, Pages 733-741

  Schmidt, H Joel ^a   Bhandari, Vineet ^b   Bhandari, Anita ^c   Davies, Jane ^d   Marshall, Bruce C ^e   Praud, Jean Paul ^f   Zar, Heather J ^g   Rubin, Bruce K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Pediatric Infectious Diseases   (United States)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e CYSTIC FIBROSIS FOUNDATION   (United States)

^f UNIVERSITÉ DE SHERBROOKE   (Canada)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

cystic fibrosis; paediatric asthma; paediatric lung disease; pneumonia; sleep apnoea

Indexed keywords

ACETYLCYSTEINE; AMIKACIN; ANTIINFLAMMATORY AGENT; AZITHROMYCIN; AZTREONAM; BIOLOGICAL MARKER; BRONCHODILATING AGENT; CAFFEINE; CYCLOSPORIN; DENUFOSOL; DORNASE ALFA; DURAMYCIN; FOSFOMYCIN; GLUTATHIONE; HYDROXYCHLOROQUINE; IBUPROFEN; LEVOFLOXACIN; MANNITOL; NITRIC OXIDE; PANCRELIPASE; PIOGLITAZONE; RETINOL; SILDENAFIL; SIMVASTATIN; SODIUM CHLORIDE; STEROID; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN; VOLATILE AGENT;

ADENOTONSILLECTOMY; AGING; ANALYSIS; ARTERIAL PRESSURE; ASSISTED VENTILATION; ASTHMA; CHRONIC LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; EARLY DIAGNOSIS; EXPIRED AIR; GENE EXPRESSION; GENETIC MARKER; GENETICS; GOLD STANDARD; HAEMOPHILUS INFLUENZAE TYPE B; HEART DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERACTIVITY; IMAGING; INFLAMMATION; INSPIRATORY CAPACITY; KIDNEY DISEASE; LIVER DISEASE; LIVER FUNCTION TEST; LUNG ARTERY PRESSURE; LUNG CLEARANCE; LUNG DYSPLASIA; LUNG INFECTION; MIXED INFECTION; MONITORING; MORBIDITY; MORTALITY; MUCUS SECRETION; MULTIPLE ORGAN FAILURE; MUTATION; NEWBORN SCREENING; NONHUMAN; OBESITY; ORTHODONTICS; OXYGEN SATURATION; PATIENT COMPLIANCE; PATIENT IDENTIFICATION; PEDIATRICS; PHENOTYPE; PNEUMONIA; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; PULMONOLOGY; REDUCTION; REVIEW; SLEEP DISORDERED BREATHING; SNORING; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; THERAPY EFFECT; TUBERCULOSIS;

ADULT; ASTHMA; BRONCHOPULMONARY DYSPLASIA; CHILD; CHRONIC DISEASE; CYSTIC FIBROSIS; HUMANS; INFANT, NEWBORN; LUNG DISEASES; MUCUS; PEDIATRICS; PULMONARY MEDICINE; RESPIRATORY FUNCTION TESTS; SLEEP APNEA, OBSTRUCTIVE;

EID: 77953849819     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01745.x     Document Type: Review

References (51)

1. Fanaroff AA, Stoll BJ, Wright LL et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am. J. Obstet. Gynecol. 2007 196: 147 e1 8.
2. Doyle LW. Antenatal progesterone to prevent preterm birth. Lancet 2009 373: 2000 2.
3. Van Marter LJ, Allred EN, Pagano M et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000 105: 1194 201.
4. Buckmaster AG, Wright IM, Arnolda G et al. Practice variation in initial management and transfer thresholds for infants with respiratory distress in Australian hospitals. Who should write the guidelines? J. Paediatr. Child Health 2007 43: 469 75.
5. Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 2009 123: 1562 73.
6. Geary C, Caskey M, Fonseca R et al. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study. Pediatrics 2008 121: 89 96.
7. Bhandari V, Finer NN, Ehrenkranz RA et al. Synchronized nasal intermittent positive-pressure ventilation and neonatal outcomes. Pediatrics 2009 124: 517 26.
8. Morley CJ, Davis PG, Doyle LW et al. Nasal CPAP or intubation at birth for very preterm infants. N. Engl. J. Med. 2008 358: 700 8.
9. Doyle LW, Davis PG, Morley CJ et al. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone. Pediatrics 2007 119: 716 21.
10. Bhandari V. Making babies breathe better: hopeful signals? Pediatr. Res. 2008 64: 123 4.
11. Gross NJ. What is this thing called love?-or, defining asthma. Am. Rev. Respir. Dis. 1980 121: 203 4.
12. von Mutius E. Gene-environment interactions in asthma. J. Allergy Clin. Immunol. 2009 123: 3 11.
13. Holt PG, Upham JW, Sly PD. Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J. Allergy Clin. Immunol. 2005 116: 16 24.
14. Rubin BK. Editorial overview: the value of FeNO measurement in asthma management Fire sticks and burning bushes-maybe NO, but perhaps yes. Paediatr. Respir. Rev. 2008 9: 132 33.
15. Rubin BK. What does it mean when a patient says, 'My asthma medication is not working?' Chest 2004 126: 972 81.
16. Priftis KN, Rubin BK. Atelectasis, middle lobe syndrome, plastic bronchitis. In: Priftis KN, Anthracopoulos MB, Eber E, Koumbourlis AC, Wood RE. Progress in Respiratory Research. Pediatr. Bronchoscopy (in press).
17. Aikawa T, Shimura S, Sasaki H et al. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992 101: 916 21.
18. Liu M, Wang L, Li E et al. Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea-pigs. Clin. Exp. Allergy 1996 26: 270 305.
19. Okamoto K, Kim J-S, Rubin BK. Secretory phospholipases A2 stimulate mucus secretion, induce airway inflammation, and produce secretory hyperresponsiveness to neutrophil elastase in the ferret trachea. Am. J. Physiol. Lung Cell Mol. Physiol. 2007 292: L62 67.
20. Fonseca-Aten M, Okada PJ, Bowlware KL et al. Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial. Ann. Allergy Asthma Immunol. 2006 97: 457 63.
21. Rubin BK, Fink JB. Novel medications for asthma: a look at the future. Expert Opin. Investing. Drugs 2007 16: 889 97.
22. Cystic Fibrosis Foundation. 2009. Drug Development Pipeline Accessed 9 November 2009.] Available from URL: http://www.cff.org/research/ DrugDevelopmentPipeline/
23. Sontag MK, Corey M, Hokanson JE et al. Genetic and physiologic correlates of longitudinal immuno reactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening. J. Pediatr. 2006 149: 650 7.
24. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull. World Health Organ. 2008 86: 408 16.
25. Marais BJ, Hesseling AC, Gie RP et al. The burden of childhood tuberculosis and the accuracy of community based surveillance data. Int. J. Tuber Lung Dis. 2006 10: 259 63.
26. UNAIDS. AIDS epidemic update: special report on HIV/AIDS. 2008 Accessed 11 March 2010.] Available from URL: http://www.unaids.org/en/KnowledgeCentre/ HIVData/GlobalReport/2008/
27. Gray D, Zar HJ. Management of community-acquired pneumonia in HIV-infected children. Expert Rev. Anti. Infect. Ther. 2009 7: 437 51.
28. Sazawal S, Black RE, Pneumonia Case Management Trials Group. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect. Dis. 2003 3: 547 56.
29. Cutts FT, Zaman SM, Enwere G et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005 365 (9465 1139 46.
30. Klugman KP, Madhi SA, Huebner RE et al. A trial of 9-valent pneumococcal conjugate vaccine in children with and without HIV infection. N. Engl. J. Med. 2003 349: 1341 8.
31. Klugman KP, Chien YW, Madhi SA. Pneumococcal pneumonia and influenza: a deadly combination. Vaccine 2009 27 (Suppl. 3 C9 14.
32. Zar HJ, Connell T, Nicol M. Diagnosis of pulmonary tuberculosis in children-new advances. Exp. Review. Infect. Ther. 2010 8: 277 88.
33. Diacon AH, Pym A, Grobusch M et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N. Engl. J. Med. 2009 360: 2397 405.
34. Aagaard C, Dietrich J, Doherty M et al. TB vaccines: current status and future perspectives. Immunol. Cell Biol. 2009 87: 279 86.
35. Guilleminault C, Huang YS, Glamann C et al. Adenotonsillectomy and obstructive sleep apnea in children: a prospective survey. Otolaryngol. Head Neck Surg. 2007 136: 169 75.
36. Praud JP, Dorion D. Obstructive sleep disordered breathing in children: beyond adenotonsillectomy. Pediatr. Pulmonol. 2008 43: 837 43.
37. Spicuzza L, Leonardi S, La Rosa M. Pediatric sleep apnea: early onset of the 'syndrome'? Sleep Med. Rev. 2009 13: 111 22.
38. Beebe DW. Neurobehavioral morbidity associated with disordered breathing during sleep in children: a comprehensive review. Sleep 2006 29: 1115 34.
39. Bhattacharjee R, Kheirandish-Gozal L, Pillar G et al. Cardiovascular complications of obstructive sleep apnea syndrome: evidence from children. Prog. Cardiovasc. Dis. 2009 51: 416 33.
40. Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. American Academy of Pediatrics. Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002 109: 704 12.
41. Collop NA, Anderson WM, Boehlecke B et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J. Clin. Sleep Med. 2007 3: 737 47.
42. Kheirandish-Gozal L, Gozal D. The multiple challenges of obstructive sleep apnea in children: diagnosis. Curr. Opin. Pediatr. 2008 20: 650 3.
43. Arnardottir ES, Mackiewicz M, Gislason T et al. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009 32: 447 70.
44. Stocks J, Coates A, Bush A. Lung function in infants and young children with chronic lung disease of infancy: the next steps? Pediatr. Pulmonol. 2007 42: 3 9.
45. Gustafsson PM. Inert gas washout in preschool children. Paediatr. Respir. Rev. 2005 6: 239 45.
46. Tiddens HA. Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Paediatr. Respir. Rev. 2006 7: 202 8.
47. Bush A, Eber E. The value of FeNO measurement in asthma management: the motion for Yes, it's NO-or, the wrong end of the Stick! Paediatr. Respir. Rev. 2008 9: 127 31.
48. Gogate S, Katial R. Pediatric biomarkers in asthma: exhaled nitric oxide, sputum eosinophils and leukotriene E4. Curr. Opin. Allergy Clin. Immunol. 2008 8: 154 7.
49. Ordoñez CL, Kartashov AI, Wohl ME. Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis. J. Pediatr. 2004 145: 689 92.
50. Harris JK, De Groote MA, Sagel SD et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc. Natl. Acad. Sci. USA 2007 104: 20529 33.
51. Accessed 22 March 2010.] Available from URL: http://www.cfgenetherapy. org.uk/